肝细胞DUSP14维持代谢稳态并抑制肝脏炎症
本研究在高脂饮食诱导或遗传性肥胖小鼠模型中,发现肝细胞特异性过表达DUSP14可显著改善胰岛素抵抗、肝脏脂质蓄积及伴随的炎症反应,而肝细胞特异性缺失DUSP14则加重这些病理改变。机制上DUSP14直接结合并去磷酸化TAK1,抑制TAK1及其下游JNK、p38和NF-κB的活化;抑制TAK1活性可减轻DUSP14-HKO小鼠高脂饮食后的糖脂代谢表型恶化。
要点
- 肝细胞过表达DUSP14改善高脂饮食或遗传性肥胖小鼠的胰岛素抵抗、肝脂蓄积和炎症。
- 肝细胞缺失DUSP14加重上述病理改变,抑制TAK1可减轻该恶化。
- DUSP14的保护作用依赖其与TAK1的结合结构域及磷酸酶活性。
核心结论
- 肝细胞DUSP14是维持肝脏代谢稳态和抑制炎症所必需的,其新功能依赖于约束TAK1过度活化。
研究设计与样本
- 在高脂饮食诱导或遗传性肥胖小鼠模型中,采用肝细胞特异性DUSP14过表达(DUSP14-HTG)和肝细胞特异性DUSP14缺失(DUSP14-HKO)进行在体研究。
主要发现
- 肝细胞特异性DUSP14过表达(DUSP14-HTG)在高脂饮食诱导或遗传性肥胖小鼠模型中显著改善胰岛素抵抗、肝脏脂质蓄积及伴随的炎症反应。
- 肝细胞特异性DUSP14缺失(DUSP14-HKO)加重上述病理改变。
- DUSP14直接结合并去磷酸化TAK1,降低TAK1及其下游JNK、p38和NF-κB的活化。
- 抑制TAK1活性可有效减轻高脂饮食攻击的DUSP14-HKO小鼠糖脂代谢表型的恶化。
- DUSP14与TAK1的结合结构域及磷酸酶活性均是其对抗肝脏脂肪变所必需,打断DUSP14-TAK1相互作用可消除DUSP14的缓解效应。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) is a prevalent and complex disease that confers a high risk of severe liver disorders. Despite such public and clinical health importance, very few effective therapies are currently available for NAFLD. We report a protective function and the underlying mechanism of dual-specificity phosphatase 14 (DUSP14) in NAFLD and related metabolic disorders. Insulin resistance, hepatic lipid accumulation, and concomitant inflammatory responses, key pathological processes involved in NAFLD development, were significantly ameliorated by hepatocyte-specific DUSP14 overexpression (DUSP14-HTG) in high-fat diet (HFD)-induced or genetically obese mouse models. By contrast, specific DUSP14 deficiency in hepatocytes (DUSP14-HKO) aggravated these pathological alterations. We provided mechanistic evidence that DUSP14 directly binds to and dephosphorylates transforming growth factor β-activated kinase 1 (TAK1), resulting in the reduced activation of TAK1 and its downstream signaling molecules c-Jun N-terminal kinase 1 (JNK), p38, and nuclear factor kappa B NF-κB. This effect was further evidenced by the finding that inhibiting TAK1 activity effectively attenuated the deterioration of glucolipid metabolic phenotype in DUSP14-HKO mice challenged by HFD administration. Furthermore, we identified that both the binding domain and the phosphatase activity of DUSP14 are required for its protective role against hepatic steatosis, because interruption of the DUSP14-TAK1 interaction abolished the mitigative effects of DUSP14. CONCLUSION: Hepatocyte DUSP14 is required for maintaining hepatic metabolic homeostasis and for suppressing inflammation, a novel function that relies on constraining TAK1 hyperactivation. (Hepatology 2018;67:1320-1338).
引用
- Wang S, Yan ZZ, Yang X, et al. Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver. Hepatology. 2018. PMID: 29077210. doi:10.1002/hep.29616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。